DAN PUCKETT - 01 Sep 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
01 Sep 2021
Net transactions value
-$503,089
Form type
4
Filing time
02 Sep 2021, 21:28:37 UTC
Previous filing
04 Aug 2021
Next filing
04 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $38,233 +2,249 +4.9% $17.00* 48,037 01 Sep 2021 Direct F1
transaction SWAV Common Stock Options Exercise $1,012 +251 +0.52% $4.03* 48,288 01 Sep 2021 Direct F1
transaction SWAV Common Stock Sale $38,150 -179 -0.37% $213.13 48,109 01 Sep 2021 Direct F1, F2
transaction SWAV Common Stock Sale $42,866 -200 -0.42% $214.33 47,909 01 Sep 2021 Direct F1, F3
transaction SWAV Common Stock Sale $21,575 -100 -0.21% $215.75 47,809 01 Sep 2021 Direct F1, F4
transaction SWAV Common Stock Sale $374,300 -1,721 -3.6% $217.49 46,088 01 Sep 2021 Direct F1, F5
transaction SWAV Common Stock Sale $65,442 -300 -0.65% $218.14 45,788 01 Sep 2021 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Employee Stock Option (Right to Buy) Options Exercise $0 -251 -8.3% $0.000000 2,761 01 Sep 2021 Common Stock 251 $4.03 Direct F1, F7, F9
transaction SWAV Employee Stock Option (Right to Buy) Options Exercise $0 -2,249 -8.3% $0.000000 24,745 01 Sep 2021 Common Stock 2,249 $17.00 Direct F1, F8, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.85 to $213.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $214.31 to $214.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The reported securities were sold at a price of $215.75
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.92 to $217.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.08 to $218.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 1/48th of the shares subject to the option shall vest monthly from 07/19/2018.
F8 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.
F9 The holdings reported on 4/19/2021 for this option were inadvertently reported as 5,066 and should have been reported as 4,724. The holdings in this form are correct.
F10 The holdings reported on 6/1/2021 for this option were inadvertently reported as 31,665 and should have been reported as 30,808. The holdings in this form are correct.